Published April 2018 | Version v1
Journal article Metadata-only

Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis

Creators

  • 1. German Cancer Research Center (DKFZ), Heidelberg (Germany)
  • 2. German Cancer Consortium (DKTK), partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen (Germany)
  • 3. Department of Radiation Oncology, University Hospital, LMU Munich (Germany)
  • 4. Heidelberg Institute for Radiation Oncology (HIRO) (Germany)
  • 5. Department of Radiation Oncology, University of Heidelberg (Germany)

Description

Background and purpose: Reirradiation (reRT) is a valid option with considerable efficacy in patients with recurrent high-grade glioma, but it is still not known which patients might be optimal candidates for a second course of irradiation. This study validated a newly developed prognostic score independently in an external patient cohort.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2018.01.011

Additional details

Identifiers

DOI
10.1016/j.radonc.2018.01.011;
PII
S0167814018300331;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
127
Journal Issue
1
Journal Page Range
p. 121-127
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51004964
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
GLIOMAS; HAZARDS; IRRADIATION; PATIENTS; VALIDATION
Descriptors DEC
DISEASES; NEOPLASMS; NERVOUS SYSTEM DISEASES; TESTING

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.